Mode
Text Size
Log in / Sign up
Phase 3 Completed N=3,816 Randomized Treatment

A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline

Source: ClinicalTrials.gov NCT01502306 ↗
Enrolled (actual)
3,816
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcomePrimary: 30-day Abstinence — 168; 237; 302 Participants
◆ Published Evidence
Established
21citations · ~3 / year
Incentives and Patches for Medicaid Smokers: An RCT.
American journal of preventive medicine · 2018 · Likely link

Summary

California Smokers' Helpline will conduct a randomized trial to evaluate 3 strategies of services and/or incentives on smoking cessation rates. This project has the following specific aims: 1. To increase tobacco cessation among Medi-Cal beneficiaries who currently smoke, and to improve the management of diabetes and other chronic disease by means of tobacco cessation. 2. Demonstrate that tobacco cessation benefits that are well promoted and barrier free and include modest incentives, are effective in reducing smoking prevalence, lowering Medi-Cal health care costs, and improving health outcomes for diabetes management in particular.

Linked Publications

  • Incentives and Patches for Medicaid Smokers: An RCT.
    American journal of preventive medicine · 2018 · 21 citations · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
30-day Abstinence
168; 237; 302
SECONDARY
Percentage of Smokers Making a 24-hour Quit Attempt
546; 847; 962
SECONDARY
Continuous Abstinence Rates for Those Who Made Quit Attempts
90; 145; 185
SECONDARY
7-day Prevalence.
162; 231; 298

Eligibility Criteria

Inclusion Criteria

  • 18 years or older
  • Medi-Cal beneficiary with valid Medi-Cal beneficiary ID
  • Willing to link Helpline data with Medi-Cal utilization data
  • English or Spanish speaking
  • Valid phone number
  • Valid address
  • Gave consent to participate in study and evaluation

Exclusion Criteria

  • Contraindication(s) to nicotine patches and no MD approval
  • Pregnant
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01502306) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search